ArticleRedox biology2026
PKM2 from hyperactive neuron aggravate lung injury post-stroke by promoting FOXO3A/TXNIP mitochondria translocation in mice.
Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic stroke patients frequently develop acute lung injury (ALI), but the pathogenesis of stroke-induced ALI remains elusive. While reperfusion therapy improves stroke survival, it fails to mitigate systemic complications. Therefore, clarifying mechanisms, identifying predictors, and developing distal-targeted therapies for stroke-associated lung injury are unmet medical need. Here, we identified the serum pyruvate kinase M2 (PKM2), a modulator of systemic inflammation, exhibit predictive value for assessing severity and outcomes of stroke patients. Using a mouse model of ischemic stroke, circulating PKM2 derived from neural hyperactivity in the ipsilesional primary motor cortex (M1) was found to be related to stroke-induced ALI. Mechanistically, PKM2 loaded in extracellular vesicles (EVs) from activated neurons target alveolar epithelial cells (AEC) via blood circulating and bind to Forkhead Box O3 (FOXO3A), induce its S252 phosphorylation, and promote PKM2/FOXO3A/thioredoxin-interacting protein (TXNIP) mitochondria translocation and reactive oxygen species production in mouse AEC. Finally, a pulmonary surfactant liposome loaded with interfering peptide are designed to target and disrupt PKM2-FOXO3A interaction exerting lung protective effects in a mouse model of ischemic stroke. Summarily, PKM2 from activated neurons mediates intercellular crosstalk between brain-lung via host target proteins FOXO3A/TXNIP, contributing to AEC mitochondrial dysfunction and stroke-induced ALI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.